24HourWire

24HourWire

News from all angles

CNBC Center

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines.

Redirecting to CNBC in 3 seconds...

Read Now → Explore 24HourWire

Share this story with your network